Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,768 | 402 | 98.3% |
| Education | $138.21 | 4 | 1.5% |
| Consulting Fee | $17.07 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,008 | 176 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,369 | 76 | $0 (2024) |
| Janssen Biotech, Inc. | $580.28 | 29 | $0 (2024) |
| Boston Scientific Corporation | $404.35 | 15 | $0 (2023) |
| Celgene Corporation | $311.13 | 16 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $271.80 | 9 | $0 (2024) |
| Penumbra, Inc. | $241.70 | 2 | $0 (2018) |
| Ironwood Pharmaceuticals, Inc | $216.51 | 12 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $200.55 | 7 | $0 (2017) |
| Merck Sharp & Dohme LLC | $192.95 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $628.38 | 29 | ABBVIE INC. ($293.10) |
| 2023 | $1,087 | 51 | ABBVIE INC. ($483.19) |
| 2022 | $1,582 | 80 | ABBVIE INC. ($689.55) |
| 2021 | $1,900 | 99 | AbbVie Inc. ($738.29) |
| 2020 | $572.50 | 30 | AbbVie Inc. ($287.67) |
| 2019 | $675.46 | 32 | AbbVie, Inc. ($320.66) |
| 2018 | $1,345 | 45 | AbbVie, Inc. ($612.21) |
| 2017 | $1,133 | 41 | AbbVie, Inc. ($583.12) |
All Payment Transactions
407 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Immunology | ||||||
| 05/31/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Immunology | ||||||
| 05/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Gastroenterology | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Gastroenterology | ||||||
| 04/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Immunology | ||||||
| 04/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Gastroenterology | ||||||
| 04/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Immunology | ||||||
| 04/03/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Gastroenterology | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Immunology | ||||||
| 02/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 597 | 673 | $313,211 | $71,762 |
| 2022 | 13 | 694 | 1,014 | $313,345 | $74,353 |
| 2021 | 15 | 870 | 1,422 | $394,851 | $98,570 |
| 2020 | 17 | 953 | 1,509 | $404,321 | $100,967 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 139 | 142 | $115,020 | $19,345 | 16.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 138 | 140 | $75,880 | $10,725 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 144 | $19,584 | $9,524 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 85 | $17,425 | $8,701 | 49.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 34 | 35 | $37,590 | $7,302 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $11,412 | $4,726 | 41.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $13,248 | $3,328 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 18 | $7,128 | $2,614 | 36.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $8,206 | $2,160 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,715 | $1,944 | 41.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 21 | $3,003 | $1,392 | 46.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 125 | 129 | $104,490 | $17,329 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 242 | $32,981 | $16,740 | 50.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 103 | $55,826 | $8,468 | 15.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 89 | 285 | $36,500 | $7,243 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $14,760 | $5,611 | 38.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 24 | 26 | $27,924 | $4,759 | 17.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $11,404 | $3,016 | 26.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 32 | 42 | $7,092 | $2,943 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,657 | $2,558 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $5,148 | $2,164 | 42.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 35 | $5,005 | $2,095 | 41.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 16 | 16 | $2,123 | $915.75 | 43.1% |
| 43450 | Dilation of esophagus | Facility | 2022 | 15 | 15 | $3,435 | $511.15 | 14.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 115 | 118 | $95,580 | $16,718 | 17.5% |
About Tal Hazan
Tal Hazan is a Gastroenterology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497967376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tal Hazan has received a total of $8,923 in payments from pharmaceutical and medical device companies, with $628.38 received in 2024. These payments were reported across 407 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,768).
As a Medicare-enrolled provider, Hazan has provided services to 3,114 Medicare beneficiaries, totaling 4,618 services with total Medicare billing of $345,652. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Raleigh, NC
- Active Since 05/04/2007
- Last Updated 03/05/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497967376
Products in Payments
- XIFAXAN (Drug) $1,368
- Humira (Biological) $576.41
- CREON (Drug) $529.77
- LINZESS (Drug) $526.92
- HUMIRA (Biological) $492.96
- RINVOQ (Biological) $463.52
- Mavyret (Drug) $413.42
- ZEPOSIA (Drug) $343.73
- SKYRIZI (Biological) $312.97
- REMICADE (Biological) $289.17
- STELARA (Biological) $270.08
- Penumbra System (Device) $241.70
- OCALIVA (Drug) $239.08
- INJECTAFER (Drug) $186.98
- EXALT (Device) $166.49
- MAVYRET (Drug) $163.94
- DUPIXENT (Biological) $139.98
- ZEPATIER (Drug) $128.14
- Linzess (Drug) $119.44
- Creon (Drug) $110.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Raleigh
Sanjay Jagannath, M.d, M.D
Gastroenterology — Payments: $68,773
Dr. Alyson Johnson, Md, MD
Gastroenterology — Payments: $51,083
Dr. Rig Patel, Md, MD
Gastroenterology — Payments: $45,372
Dr. Henry Vanpala, M.d, M.D
Gastroenterology — Payments: $43,522
Neeraj Sachdeva, Md, MD
Gastroenterology — Payments: $20,208
Murtaza Parekh, Md, MD
Gastroenterology — Payments: $13,298